Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D05QIK
|
|||
| Drug Name |
CM4620
|
|||
| Synonyms |
CM-4620; 1713240-67-5; CM4620; SCHEMBL18038390; GTPL10087; CM4620; EX-A1898; BCP29536; CM 4620; compound I [WO2016138472A1]; SB18686; AK549808; HY-101942; CS-0022201
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Coronavirus Disease 2019 (COVID-19) [ICD-11: 1D6Y] | Phase 2 | [1] | |
| Therapeutic Class |
Antiviral Agents
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C19H11ClF3N3O3
|
|||
| Canonical SMILES |
CC1=C(C(=CC=C1)F)C(=O)NC2=NC=C(N=C2)C3=CC4=C(C=C3Cl)OC(O4)(F)F
|
|||
| InChI |
1S/C19H11ClF3N3O3/c1-9-3-2-4-12(21)17(9)18(27)26-16-8-24-13(7-25-16)10-5-14-15(6-11(10)20)29-19(22,23)28-14/h2-8H,1H3,(H,25,26,27)
|
|||
| InChIKey |
QQMKTHUGOQDEIL-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04345614) A Study of CM4620-Injectable Emulsion (IE) in Patients With Severe COVID-19 Pneumonia. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.